✦ LIBER ✦

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)

✍ Scribed by Larson, R A; Boogaerts, M; Estey, E; Karanes, C; Stadtmauer, E A; Sievers, E L; Mineur, P; Bennett, J M; Berger, M S; Eten, C B

Book ID: 110055233
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 163 KB
Volume: 16
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402677

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin as first-line trea

Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia

✍ Wassim McHayleh; Kenneth Foon; Robert Redner; Rajesh Sehgal; Anastasios Raptis; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Licensure of Gemtuzumab Ozogamicin for t

Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse

✍ Mark S. Berger; Lance H. Leopold; James A. Dowell; Joan M. Korth-Bradley; Matthe 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 141 KB

Final report of the efficacy and safety

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

✍ Richard A. Larson; Eric L. Sievers; Edward A. Stadtmauer; Bob Löwenberg; Elihu H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB 👁 1 views

Phase I/II study of humanized anti-CD33

Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study

✍ Yukio Kobayashi; Kensei Tobinai; Akihiro Takeshita; Kensuke Naito; Osamu Asai; N 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

Sequence of administration and methylati

Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)

✍ Iris Middeldorf; Oliver Galm; Rainhardt Osieka; Edgar Jost; James G. Herman; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

Fractionated doses of gemtuzumab ozogami

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association

✍ Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views